Publicações

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Vergote I.;	2	Scambia G.;	3	O'Malley D.M.;
4	Van Calster B.;	5	Park S.Y.;	6	del Campo J.M.;
7	Meier W.;	8	Bamias A.;	9	Colombo N.;
10	Wenham R.M.;	11	Covens A.;	12	Marth C.;
13	Raza Mirza M.;	14	Kroep J.R.;	15	Ma H.;
16	Pickett C.A.;	17	Monk B.J.;	18	Park S.Y.;
19	Song Y.S.;	20	Makarova Y.;	21	Trinidad J.;
22	Ngan H.Y.S.;	23	Aravantinos G.;	24	Nam J.H.;
25	Gorbunova V.;	26	Krikunova L.;	27	Bae D.S.;
28	Arija J.A.A.;	29	Mirza M.R.;	30	Zamagni C.;
31	Papandreou C.;	32	Raspagliesi F.;	33	Lisyanskaya A.;
34	Benzaquen A.O.;	35	Tognon G.;	36	Ortega E.;
37	Herraez A.C.;	38	Buscema J.;	39	Green A.;
40	Burger R.;	41	Sakaeva D.;	42	Sanchez A.R.;
43	Ghamande S.;	44	King L.;	45	Petru E.;
46	Peen U.;	47	Takeuchi S.;	48	Ushijima K.;
49	Martin A.G.;	50	Kamelle S.;	51	Carney M.;
52	Forget F.;	53	Bentley J.;	54	Sehouli J.;
55	Zola P.;	56	Kato H.;	57	Fadeeva N.;
58	Gotovkin E.;	59	Vladimirov V.;	60	Marin M.R.;
61	Alia E.G.;	62	Shahin M.;	63	Bhoola S.;
64	Tewari K.;	65	Anderson D.;	66	Honhon B.;
67	Pelgrims J.(.;	68	Oza A.;	69	Jimenez J.G.D.;
70	Hansen V.;	71	Benjamin I.;	72	Renard V.;
73	Van den Bulck H.;	74	Haenle C.;	75	Koumakis G.;
76	Yokota H.;	77	Popov V.;	78	Bradley W.;
79	Wenham R.;	80	Reid R.;	81	McNamara D.;
82	Friedman R.;	83	Barlin J.;	84	Spirtos N.;
85	Chapman J.;	86	Sevelda P.;	87	Huizing M.;
88	Lamot C.;	89	Goffin F.;	90	Hondt L.D.;
91	Covens A.;	92	Spadafora S.;	93	Rautenberg B.;
94	Reimer T.;	95	Möbus V.;	96	Hilpert F.;
97	Gropp-Meier M.;	98	Savarese A.;	99	Pignata S.;
100	Verderame F.;

Trebananib or Placebo plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Ovarian Cancer (Trinova-3/Engot-Ov2/Gog-3001): a Randomised, Double-Blind, Phase 3 Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Trebananib or Placebo plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Ovarian Cancer (Trinova-3/Engot-Ov2/Gog-3001): a Randomised, Double-Blind, Phase 3 Trial

Links Úteis

Ajuda